Clinical Trial Update: Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial of KOS-862 (Epothilone D) in metastatic prostate cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• KOS-862 (Epothilone D)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED